TY - JOUR
T1 - The impact of perioperative stroke and delirium on outcomes after surgical aortic valve replacement
AU - Cardiothoracic Surgical Trials Network (CTSN) Investigators
AU - Messé, Steven R.
AU - Overbey, Jessica R.
AU - Thourani, Vinod H.
AU - Moskowitz, Alan J.
AU - Gelijns, Annetine C.
AU - Groh, Mark A.
AU - Mack, Michael J.
AU - Ailawadi, Gorav
AU - Furie, Karen L.
AU - Southerland, Andrew M.
AU - James, Michael L.
AU - Moy, Claudia Scala
AU - Gupta, Lopa
AU - Voisine, Pierre
AU - Perrault, Louis P.
AU - Bowdish, Michael E.
AU - Gillinov, A. Marc
AU - O'Gara, Patrick T.
AU - Ouzounian, Maral
AU - Whitson, Bryan A.
AU - Mullen, John C.
AU - Miller, Marissa A.
AU - Gammie, James S.
AU - Pan, Stephanie
AU - Erus, Guray
AU - Browndyke, Jeffrey N.
AU - Taddei-Peters, Wendy C.
AU - Jeffries, Neal O.
AU - Buxton, Dennis
AU - Geller, Nancy L.
AU - Gordon, David
AU - Burke, Catherine
AU - Lee, Albert
AU - Smith, Tyrone
AU - Moy, Claudia S.
AU - Gombos, Ilana Kogan
AU - Weisel, Richard
AU - Gardner, Timothy J.
AU - Rose, Eric A.
AU - Parides, Michael K.
AU - Ascheim, Deborah D.
AU - Bagiella, Emilia
AU - Moquete, Ellen
AU - Shah, Kinjal
AU - Chang, Helena
AU - Chase, Melissa
AU - Goldfarb, Seth
AU - Kirkwood, Katherine
AU - Kron, Irving L.
AU - Bull, David A.
N1 - Publisher Copyright:
© 2022 The American Association for Thoracic Surgery
PY - 2024/2
Y1 - 2024/2
N2 - Objective: The effects of stroke and delirium on postdischarge cognition and patient-centered health outcomes after surgical aortic valve replacement (SAVR) are not well characterized. Here, we assess the impact of postoperative stroke and delirium on these health outcomes in SAVR patients at 90 days. Methods: Patients (N = 383) undergoing SAVR (41% received concomitant coronary artery bypass graft) enrolled in a randomized trial of embolic protection devices underwent serial neurologic and delirium evaluations at postoperative days 1, 3, and 7 and magnetic resonance imaging at day 7. Outcomes included 90-day functional status, neurocognitive decline from presurgical baseline, and quality of life. Results: By postoperative day 7, 25 (6.6%) patients experienced clinical stroke and 103 (28.5%) manifested delirium. During index hospitalization, time to discharge was longer in patients experiencing stroke (hazard ratio, 0.62; 95% confidence interval [CI], 0.42-0.94; P = .02) and patients experiencing delirium (hazard ratio, 0.68; 95% CI, 0.54-0.86; P = .001). At day 90, patients experiencing stroke were more likely to have a modified Rankin score >2 (odds ratio [OR], 5.9; 95% CI, 1.7-20.1; P = .01), depression (OR, 5.3; 95% CI, 1.6-17.3; P = .006), a lower 12-Item Short Form Survey physical health score (adjusted mean difference −3.3 ± 1.9; P = .08), and neurocognitive decline (OR, 7.8; 95% CI, 2.3-26.4; P = .001). Delirium was associated with depression (OR, 2.2; 95% CI, 0.9-5.3; P = .08), lower 12-Item Short Form Survey physical health (adjusted mean difference −2.3 ± 1.1; P = .03), and neurocognitive decline (OR, 2.2; 95% CI, 1.2-4.0; P = .01). Conclusions: Stroke and delirium occur more frequently after SAVR than is commonly recognized, and these events are associated with disability, depression, cognitive decline, and poorer quality of life at 90 days postoperatively. These findings support the need for new interventions to reduce these events and improve patient-centered outcomes.
AB - Objective: The effects of stroke and delirium on postdischarge cognition and patient-centered health outcomes after surgical aortic valve replacement (SAVR) are not well characterized. Here, we assess the impact of postoperative stroke and delirium on these health outcomes in SAVR patients at 90 days. Methods: Patients (N = 383) undergoing SAVR (41% received concomitant coronary artery bypass graft) enrolled in a randomized trial of embolic protection devices underwent serial neurologic and delirium evaluations at postoperative days 1, 3, and 7 and magnetic resonance imaging at day 7. Outcomes included 90-day functional status, neurocognitive decline from presurgical baseline, and quality of life. Results: By postoperative day 7, 25 (6.6%) patients experienced clinical stroke and 103 (28.5%) manifested delirium. During index hospitalization, time to discharge was longer in patients experiencing stroke (hazard ratio, 0.62; 95% confidence interval [CI], 0.42-0.94; P = .02) and patients experiencing delirium (hazard ratio, 0.68; 95% CI, 0.54-0.86; P = .001). At day 90, patients experiencing stroke were more likely to have a modified Rankin score >2 (odds ratio [OR], 5.9; 95% CI, 1.7-20.1; P = .01), depression (OR, 5.3; 95% CI, 1.6-17.3; P = .006), a lower 12-Item Short Form Survey physical health score (adjusted mean difference −3.3 ± 1.9; P = .08), and neurocognitive decline (OR, 7.8; 95% CI, 2.3-26.4; P = .001). Delirium was associated with depression (OR, 2.2; 95% CI, 0.9-5.3; P = .08), lower 12-Item Short Form Survey physical health (adjusted mean difference −2.3 ± 1.1; P = .03), and neurocognitive decline (OR, 2.2; 95% CI, 1.2-4.0; P = .01). Conclusions: Stroke and delirium occur more frequently after SAVR than is commonly recognized, and these events are associated with disability, depression, cognitive decline, and poorer quality of life at 90 days postoperatively. These findings support the need for new interventions to reduce these events and improve patient-centered outcomes.
KW - aortic valve
KW - delirium
KW - neurological outcomes
KW - perioperative management
KW - surgical aortic valve replacement (SAVR)
UR - http://www.scopus.com/inward/record.url?scp=85125616241&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125616241&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2022.01.053
DO - 10.1016/j.jtcvs.2022.01.053
M3 - Article
C2 - 35483981
AN - SCOPUS:85125616241
SN - 0022-5223
VL - 167
SP - 624-633.e4
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 2
ER -